Alan Bryce named chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at TGen

How we improved the treatment of Hodgkin lymphoma

Hodgkin lymphoma has long been a model disease in the field of oncology—one of the first diseases we learned to cure with radiation and ultimately chemotherapy.

Longevity Consortium receives $45M grant

The Longevity Consortium received a five-year, $45 million grant to move the consortium’s work to its next stage: integrating results from numerous studies about the factors that contribute to longer and healthier lives.

November 01, 2024

Vol.50 No.41

Cancer History Project

Latino oncology leaders discuss representation in clinical trials, translational research, and health care
Mesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.”

Hispanic and Latino people comprise nearly 20% of the U.S. population, but less than 6% of physicians nationwide identify as Hispanic.

October 11, 2024

Vol.50 No.38

By Ruben A. Mesa and McKenzie Prillaman

In Brief

Robert Jenq named director of microbiome program at City of Hope

Robert R. Jenq was named director of the microbiome program at City of Hope and clinical professor in the Department of Hematology and Hematopoietic Cell Transplantation.

September 20, 2024

Vol.50 No.35

Clinical Roundup

Novel tumor models provide insights into deadly sarcomas

Investigators at UC Davis Comprehensive Cancer Center and UCLA Health’s Jonsson Comprehensive Cancer Center report they have manipulated mesenchymal stem cells to create four different sarcoma models.

September 20, 2024

Vol.50 No.35

Conversation with The Cancer Letter

A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease

City of Hope has received a $150 million gift from entrepreneurs and philanthropists A. Emmet Stephenson Jr. and his daughter Tessa Stephenson Brand to create a program focused on pancreatic cancer research.

September 17, 2024

Vol.50 No.35

By Paul Goldberg

Alan Bryce named chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at TGen

YOU MAY BE INTERESTED IN

How we improved the treatment of Hodgkin lymphoma

Longevity Consortium receives $45M grant

Latino oncology leaders discuss representation in clinical trials, translational research, and health care
Mesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.”

Robert Jenq named director of microbiome program at City of Hope

Novel tumor models provide insights into deadly sarcomas

A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease

Renew today!

Subscriber content

Login

Alan Bryce named chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at TGen

YOU MAY BE INTERESTED IN

How we improved the treatment of Hodgkin lymphoma

Longevity Consortium receives $45M grant

Latino oncology leaders discuss representation in clinical trials, translational research, and health careMesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.”

Robert Jenq named director of microbiome program at City of Hope

Novel tumor models provide insights into deadly sarcomas

A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease

Login

Latino oncology leaders discuss representation in clinical trials, translational research, and health care
Mesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.”